636 matches for your search in the start-up spotlight
rss
Tres Alchemix is an AI-native biotechnology company developing a predictive drug-design platform to create next-generation small-molecule therapies. By integrating multi-omic and multimodal datasets with proprietary quantum-chemical calculation methods, it is building a human in silico model ...
Biophelion GmbH, a spin-off of the Leibniz-HKI, is an innovative deep tech company in the field of biotechnology and committed to the circular bioeconomy. With the focus on extreme robustness Biophelion develops, microorganisms, reactor systems and processes.
Biophelion GmbH, a spin-off of the Leibniz-HKI, is an innovative deep tech company in the field of biotechnology and committed to the circular bioeconomy. With the focus on extreme robustness Biophelion develops, microorganisms, reactor systems and processes.
KyDo Therapeutics GmbH (KyDo) is a preclinical-stage biotechnology company committed to developing novel covalent- allosteric small molecule inhibitors with the potential to become first-in-class oncology drugs. KyDo was jointly founded by Lead Discovery Center GmbH (LDC) together with scientists ...
Watchmaker Genomics is a life sciences company pioneering high-performance enzyme engineering to enable breakthroughs in genomics, molecular diagnostics, and synthetic biology. Leveraging advanced directed evolution and precision protein design, Watchmaker develops best-in-class enzymes that ...
Mevaldi is a biotech company and a pioneer in the field of bio-based building blocks for sustainable polymers, polyesters, and polyurethanes. Since 2020, the company has been developing 3MPD: an innovative building block derived from sugars and wood residues, produced through a patented ...
Mevaldi is a biotech company and a pioneer in the field of bio-based building blocks for sustainable polymers, polyesters, and polyurethanes. Since 2020, the company has been developing 3MPD: an innovative building block derived from sugars and wood residues, produced through a patented ...
At myotwin, we are developing a data-driven platform for cardiac research and drug development. By combining human-based 3D tissues, multiparametric measurement technology and digital analysis processes, we enable better predictions - creating a paradigm shift in cardiac drug development and the ...
AffinityAI is a Danish biotechnology company specializing in AI-guided protein design. Its proprietary Designerbodies™ are fully synthetic, small proteins engineered to bind specifically to selected epitopes on target proteins. Designed and delivered significantly faster than traditional antibody ...
MRM Health is a clinical-stage biotech developing innovative microbiome-based Live Biotherapeutic Products for chronic inflammatory diseases with high unmet needs. Its CORAL® platform enables the design and manufacturing of disease-focused microbial consortia with enhanced efficacy and ...
